Disseminated intravascular coagulation is a paradoxical condition of simultaneous clotting and bleeding throughout the body.

Health · Published 30 September 2026 Swipe more like this →

In short: In disseminated intravascular coagulation, the body's delicate balance of blood clotting and clot dissolution breaks down. This leads to widespread vessel blockage and organ failure, followed by severe, uncontrollable hemorrhage. It is a high-stakes clinical emergency that remains difficult to treat, with mortality rates reaching as high as 50 percent.

Disseminated intravascular coagulation (DIC) is not a primary disease but a systemic reaction to underlying conditions like sepsis, major trauma, or cancer. Under normal homeostatic conditions, the body maintains a precise equilibrium between coagulation, which forms fibrin clots, and fibrinolysis, which breaks them down. In DIC, this regulation fails. A critical trigger is the release of tissue factor, a glycoprotein normally sequestered from the circulation. When exposed to blood—often due to vascular damage or inflammatory cytokines—it initiates a massive coagulation cascade, generating excess thrombin and widespread fibrin clots.

These clots lodge in the microcirculation, causing ischemia and end-organ damage. Simultaneously, the body consumes its own clotting factors and platelets to build these clots, leading to a paradoxical state of depletion. As the fibrinolytic system attempts to dissolve the excess fibrin, it produces degradation products that further inhibit blood clotting, resulting in severe, systemic bleeding. While traditional models emphasize this consumptive process, recent research suggests more complex mechanisms, such as the Ashwell-Morell receptor on hepatocytes, which may clear platelets from circulation to mitigate thrombosis in certain infections.

Diagnosis relies on a constellation of laboratory markers rather than a single test. The International Society of Thrombosis and Haemostasis uses a scoring system—evaluating platelet counts, prothrombin time, fibrinogen levels, and D-dimer—that achieves 91 percent sensitivity and 97 percent specificity for overt DIC. Despite these diagnostic tools, treatment remains challenging. The primary strategy is addressing the underlying trigger, such as an infection or malignancy. Transfusions of platelets or plasma are reserved for significant bleeding, but evidence supporting these interventions is limited. Because anticoagulants like heparin carry high bleeding risks, they are rarely used, leaving the prognosis for many patients grim.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• The hidden molecular dance that turns blood into a dangerous clot
• The delicate biological dance that prevents your blood from clotting inside your veins
• The delicate balance between a life-saving clot and a dangerous one
• Hemostasis is the body's rapid, life-saving response to stop bleeding after an injury.
• Stopping a bleed takes three overlapping stages, not one simple clot
• Few psychiatric diagnoses are as disputed as dissociative identity disorder
• Why your brain sees two images when you only look at one object
• Diverticulitis hurts on the left in Europe but usually on the right in Asia
• The antihistamine in Benadryl can wind some people up instead of down
• An MD means a new doctor in America but a research degree in Britain
• Why these persistent environmental pollutants linger in the human body for over a decade.
• Nearly a third of American medical students now train for a DO

More in Health, medicine and disease · More in Health · Latest · A–Z · All topics